Vir Biotechnology, Inc. (VIR) › Capital ExpendituresVir Biotechnology, Inc. (VIR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $2.74M2018: $8.19M2019: $8.94M2020: $6.55M2021: $21.82M2022: $68.01M2023: $21.57M2024: $7.30M2025: $4.83M$4.83M2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$4.83M-33.8%2024$7.30M-66.2%2023$21.57M-68.3%2022$68.01M+211.7%2021$21.82M+233.1%2020$6.55M-26.7%2019$8.94M+9.1%2018$8.19M+198.8%2017$2.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share